Ocular inserts
AssigneeYissum Research Development Co. of the Hebrew Univ. of Jerusalem
InventorAbraham Jacob Domb
Life of this patent
Estimating the term…
Loading patent…
AssigneeYissum Research Development Co. of the Hebrew Univ. of Jerusalem
InventorAbraham Jacob Domb
Estimating the term…
Absorbable ocular inserts fabricated of materials that are biologically inert, biodegradable, non-allergenic, and insoluble in tear liquid, and a method for delivering substances to the eye using the ocular insert, are disclosed. In embodiment A of the invention, the insert and method include the covalent attachment of a carboxylic acid-containing substance to be delivered to a polymer that contains pendent carboxylic acid groups, through anhydride linkages. The drug is released over time by hydrolysis of the anhydride bonds. In embodiment B of the invention, a substance to be delivered (whether or not it contains a carboxylic acid group) is dispersed within an anhydride polymer or copolymer matrix and the mixture is formed into an appropriately shaped article for ocular delivery. In embodiment C of the invention, the insert and method include the covalent attachment of a carboxylic acid-containing substance to be delivered to a polymer that contains pendent carboxylic acid groups through methylene diester bonds which degrade in vivo over time.
An ocular insert comprising a carboxylic acid-containing biologically active compound bound to a polyacid containing pendent carboxylic acid groups through an anhydride or methylene diester bond.
Dependencies are inferred from the claim text.